(+91) 022-40062982 | info@projectsinindia.com
Thane, Maharashtra Get Free Demo →
Home News Industrial Drugs & Pharmaceuticals Projects in India: 1,791 Tracked, Gujarat Leads
Drugs & Pharmaceuticals Projects in India: 1,791 Tracked, Gujarat Leads
Industrial Industrial Projects

Drugs & Pharmaceuticals Projects in India: 1,791 Tracked, Gujarat Leads

Projects India Research Desk 30 September 2026 5 min read 951 words 19 views
India's drugs and pharmaceuticals sector has 1,791 active projects tracked by Projects India, spanning API plants, bulk drug units and formulations facilities across six major states. Gujarat alone accounts for 606 tracked projects, followed by Telangana and Andhra Pradesh.

Sector Snapshot: 1,791 Pharma Projects Tracked Nationally

India's drugs and pharmaceuticals manufacturing pipeline remains one of the most active in the industrial projects space. Projects India tracks 1,791 projects in this sub-sector, with 21 new projects added in the past 90 days. The pipeline spans API synthesis, bulk drug intermediates, formulations and speciality chemical manufacturing across multiple states.

The breadth of investment — from sub-Rs 10 crore greenfield units to projects valued above Rs 1,000 crore — signals sustained capital deployment across company sizes and geographies. Suppliers and contractors operating in this space have a wide field of opportunity at varying stages of readiness.

Geography of Investment: Where the Projects Are

Gujarat dominates the tracked pipeline with 606 projects, reflecting the state's established chemical and pharmaceutical corridor, particularly around Ahmedabad and Ankleshwar. Telangana follows with 244 projects, concentrated around the Sangareddy and Hyderabad pharmaceutical clusters. Andhra Pradesh accounts for 231 projects, with activity visible in the Kurnool and Visakhapatnam belts.

Karnataka holds 214 tracked projects, Maharashtra 166, and Himachal Pradesh — home to several large formulations hubs — accounts for 59 projects in the current dataset. For suppliers deciding where to allocate sales and business development resources, Gujarat and Telangana represent the highest density of live opportunities at present.

StateTracked Projects
Gujarat606
Telangana244
Andhra Pradesh231
Karnataka214
Maharashtra166
Himachal Pradesh59

Stage Breakdown: Where Projects Stand in the Cycle

Of the 1,791 tracked projects, 637 are currently Under Approvals — the largest single cohort and the stage at which early supplier engagement is most productive. A further 361 projects have reached Construction Started, representing near-term procurement and contracting activity. An additional 137 projects carry Approvals Received status, placing them on the threshold of construction mobilisation.

98 projects remain at Planning stage, 137 are on Hold, and 323 have been recorded as Completed. The Under Approvals and Approvals Received cohorts combined account for 774 projects — a substantial addressable pipeline for equipment vendors, civil contractors and engineering service providers.

Recent Projects Entering the Pipeline

Among recently tracked projects, the most capital-intensive is a bulk drugs and drug intermediates manufacturing unit being developed by Virupaksha Organics Limited at Orvakal Node, Kurnool, Andhra Pradesh, valued at Rs 1,225 crore and currently at Planning stage. At the other end of the scale, multiple sub-Rs 25 crore greenfield and expansion projects are progressing through approvals or into construction.

ProjectPromoterLocationValue (Rs crore)Stage
Bulk Drugs & Drug Intermediates Mfg UnitVirupaksha Organics LimitedKurnool, Andhra Pradesh1,225Planning
API Bulk Drug & Intermediates Mfg Unit (Expansion)Chromo Laboratories India Private LimitedSangareddy, Telangana195Under Approvals
Pharmaceutical ProjectCentaur Pharmaceuticals Private LimitedSouth Goa, Goa42Construction Started
Active Pharmaceutical Ingredients ProjectJuvenus DrugsChennai, Tamil Nadu20Under Approvals
Dextrose Saline & Medicines Mfg Unit (Expansion)Guddodgi Pharmaceutical DistributorsVijayapura, Karnataka18Under Approvals
Bulk Drugs & Drug Intermediates Mfg UnitMole Labs Private LimitedYadgir, Karnataka10.25Under Approvals
Bulk Drugs Mfg UnitVB Genetics Private LimitedAnkleshwar, Gujarat7Construction Started
API & Intermediates Mfg ProjectDwirayu Pharma Private LimitedAhmedabad, Gujarat7.5Under Approvals
Pharmaceutical Products & Intermediates MfgSrikem Laboratories Private LimitedRaigad, Maharashtra4.49Construction Started
API & Intermediates Plant (Expansion)Chemtech Acids & Chemicals Private LimitedSangareddy, Telangana20Hold

What this means for suppliers and contractors

The concentration of 637 projects at Under Approvals stage means a significant volume of procurement decisions are approaching but have not yet been made — an optimal window for equipment vendors, process engineering firms and civil contractors to establish relationships and position bids. The 361 projects at Construction Started represent active, near-term site activity requiring immediate supply of materials, equipment and services.

Gujarat's dominance in project count makes it the single most important state for sustained business development effort. However, Telangana and Andhra Pradesh together account for 475 projects, and both states are home to large-value API and bulk drug investments that carry longer procurement cycles and larger contract values. Karnataka, with 214 projects, deserves particular attention given recent activity in Vijayapura and Yadgir districts, areas less saturated with competing suppliers than the Hyderabad corridor.

Broader policy tailwinds, including government-backed bulk drug investment incentives, continue to drive new project announcements. For context on how these schemes are shaping capital allocation, see how the PLI scheme has driven Rs 5,210 crore in bulk drug investment and how global players such as Merck Life Science are expanding Indian manufacturing capacity.

Suppliers seeking a full view of live opportunities across India's industrial projects sector can access the complete tracked pipeline on Projects India.

Frequently asked questions

How many drugs and pharmaceuticals projects are tracked in India?

Projects India currently tracks 1,791 drugs and pharmaceuticals projects across India, with 21 added in the past 90 days. Of these, 637 are Under Approvals and 361 have reached Construction Started stage, representing a broad active pipeline for suppliers and contractors.

Which states have the most pharmaceutical manufacturing projects in India?

Gujarat leads with 606 tracked projects, followed by Telangana with 244, Andhra Pradesh with 231, Karnataka with 214, Maharashtra with 166 and Himachal Pradesh with 59, according to Projects India data.

What is the largest bulk drug manufacturing project currently tracked in India?

Virupaksha Organics Limited is developing a bulk drugs and drug intermediates manufacturing unit at Orvakal Node, Kurnool, Andhra Pradesh, valued at Rs 1,225 crore. The project is currently at Planning stage according to Projects India records.

Are there open tenders for pharmaceutical or industrial projects in India right now?

Projects India currently records zero open India tenders in the Industrial Projects sector. Suppliers are advised to monitor the live tenders page for updates as new notices are published.

Drafted with AI assistance from published reports and Projects India’s own project database, then reviewed before publication.
Tags: drugs and pharmaceuticals API manufacturing bulk drugs industrial projects Gujarat pharma Telangana pharma Andhra Pradesh project pipeline
Sources: News on Projects

Access India's Most Trusted Project Intelligence

17,000+ verified private projects · 100% verified decision-maker contacts · AI-powered search across 51 sectors

Get Free Demo

Go deeper: related research

All Insights →
Data reportUpcoming Steel Plant Projects in India: Key LeadsBuyer guideSteel Plant EPC Contractors & Construction Companies IndiaData reportUpcoming Ethanol Plant Projects in India: 1,253 Leads